Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07437534
Eligibility Criteria:
Inclusion Criteria:
\* Patients aged ≥2 years of either gender.
Diagnosed with mild to moderate atopic dermatitis based on Hanifin and Rajka criteria.
SCORAD score between 15 and 40. Willing to participate and provide informed consent (from guardian for minors).
Exclusion Criteria:
\-
Exclusion Criteria:
\* Severe atopic dermatitis (SCORAD \> 40).
History of hypersensitivity to tacrolimus or crisaborole. Use of systemic immunosuppressive therapy within the past 4 weeks. Presence of secondary bacterial or viral skin infection. Pregnant or lactating females.
\-
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Study:
NCT07437534
Study Brief:
Protocol Section:
NCT07437534